Clear AllFeatured
October 17, 2022 | Dubai, UAE
JIMCO invests in Turkish fintech start-up Figopara in Series A round
JIMCO invests in Turkish fintech start-up Figopara in Series A funding round
Technology
August 23, 2022 | Dubai, UAE
JIMCO invests in biotech tissue engineering start-up VitroLabs
JIMCO invests in biotech start-up VitroLabs Inc to build and scale the world’s first pilot production of cell cultivated leather
Technology
January 6, 2022 | Vancouver, BC & Monaco
JIMCO major participation in US$ 130m funding round for General Fusion
JIMCO Technology Fund announces second major fusion energy investment, participating in US$ 130 million Series E funding round for General Fusion
Technology
December 11, 2021 | Cambridge, UK
JIMCO Life Sciences Fund participates in Cambridge Epigenetix US$ 88m
JIMCO Life Sciences Fund participates in Cambridge Epigenetix US$ 88m Series D round advancing best-in-class DNA sequencing technology platform
Life Sciences
December 1, 2021 | Cambridge, MA, USA & Monaco
JIMCO major participation in US$ 1.8 bn Series B round for CFS
JIMCO Technology Fund announces major participation in US$ 1.8 billion Series B funding round for Commonwealth Fusion Systems
Technology
July 13, 2021 | Riyadh, Saudi Arabia
JIMCO Technology Fund joins Speero US$ 1.8m pre-Series A round
The funding will accelerate Speero’s ambition to digitalize Saudi Arabia’s automotive after-sales ecosystem from spare parts sales to repair service.
Technology
June 27, 2021 | Dubai, UAE
JIMCO Life Sciences participates in EQRx US$ 500m Series B round.
Abdul Latif Jameel Health & EQRx collaboration to introduce two novel & affordable cancer treatments to 1.5bn people in Middle East Africa & Turkey.
Life Sciences
June 1, 2021 | Dubai, UAE
JIMCO Life Sciences Fund participates in Cellarity US$ 123m Series B
JIMCO Life Sciences Fund participates in Cellarity US$ 123m Series B funding to pioneer a new approach to drug discovery.
Life Sciences
March 24, 2021 | Dubai, UAE
JIMCO Life Sciences Fund in collaboration Evelo Biosciences
JIMCO Life Sciences Fund & Abdul Latif Jameel Health in collaboration with Evelo Biosciences to commercialize novel therapy for inflammatory disease.
Life Sciences
